Standout Papers
- A New Equation to Estimate Glomerular Filtration Rate (2009)
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation (1999)
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (2006)
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C (2012)
- Dapagliflozin in Patients with Chronic Kidney Disease (2020)
- Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate (2006)
- Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey (2002)
- Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis (2005)
- Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values (2007)
- Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis (2002)
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD (2008)
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate (2002)
- Factors other than glomerular filtration rate affect serum cystatin C levels (2009)
- Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis (2008)
- Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study (1997)
- Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations in the Estimation of GFR in Health and in Chronic Kidney Disease (2004)
- Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2 (2010)
- GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration (2014)
- Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial (2020)
- Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency (2019)
- A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy (2021)
Immediate Impact
2 from Science/Nature 122 standout
Citing Papers
Global soil pollution by toxic metals threatens agriculture and human health
2025 StandoutScience
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Works of Tom Greene being referenced
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tom Greene | 38211 | 17550 | 12365 | 475 | 79.0k | |
| Glenn M. Chertow | 41469 | 11265 | 11913 | 800 | 67.2k | |
| John W. Kusek | 27040 | 12694 | 8987 | 366 | 58.5k | |
| Giuseppe Remuzzi | 36624 | 17583 | 12142 | 1.3k | 92.7k | |
| Josef Coresh | 49539 | 29995 | 15647 | 936 | 112.1k | |
| Andrew S. Levey | 64184 | 30240 | 17388 | 503 | 121.9k | |
| Christopher H. Schmid | 13389 | 10109 | 9790 | 392 | 60.9k | |
| Dick de Zeeuw | 19532 | 18627 | 7513 | 818 | 51.7k | |
| Kamyar Kalantar‐Zadeh | 29591 | 6605 | 8203 | 905 | 50.2k | |
| Eberhard Ritz | 19039 | 13530 | 5986 | 926 | 43.6k | |
| George L. Bakris | 11719 | 34537 | 10455 | 836 | 66.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...